Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Brachytherapy Stories

2013-11-27 08:25:31

Results of Review¹ by Harley Street and University College Hospital London Presented in Online Edition of 'Radiotherapy and Oncology' (Green Journal) LONDON, Nov. 27, 2013 /PRNewswire/ -- Treating early stage non-small-cell lung cancer (NSCLC) patients with advanced radiotherapy appears to be a viable alternative to surgery, according to researchers who carried out a retrospective comparative study sponsored by the London-based South East Cancer Oncology Group. A review was...

2013-11-20 12:28:46

CORALVILLE, Iowa, Nov. 20, 2013 /PRNewswire/ -- CIVCO Medical Solutions advances the standard in real-time planning with FDA 510(k) clearance of the EX3 Stepper for Low Dose Rate (LDR) and High Dose Rate (HDR) ultrasound-guided brachytherapy for prostate cancer detection and treatment. (Logo: http://photos.prnewswire.com/prnh/20110419/AQ85801LOGO) LDR prostate brachytherapy involves internal radiotherapy where tiny radioactive 'seeds' are delivered through a needle and are...

2013-11-18 23:21:18

Woman Remains Cancer-Free 13 Years after Participating in Breast Cancer Study Royal Oak, MI (PRWEB) November 18, 2013 Beaumont Hospital in Royal Oak, Mich. presented updated research results at this year’s American Society for Radiation Oncology conference. The outcomes showed that APBI, and traditional whole-breast irradiation are comparable at 10 years. While radiation therapy has traditionally been delivered using whole breast irradiation, APBI is a proven alternative that shortens...

2013-11-05 08:35:54

Hospital La Fe's study demonstrates user- and patient-friendliness and short procedure time with Esteya VALENCIA, Spain, Nov. 5, 2013 /PRNewswire/ -- Hospital La Fe, a long-time clinical collaborator of Nucletron, an Elekta company, is nearing the conclusion of the enrollment phase of a clinical study with the new Esteya® electronic brachytherapy system for treating skin cancer. First clinical data on efficacy are expected in about two months, but physicians in the center's...

2013-10-24 12:26:11

CHICAGO, Oct. 24, 2013 /PRNewswire/ -- LUGPA, an organization advocating for integrated and coordinated urological care with more than 2,000 physician experts across the U.S., has carefully reviewed the article "Urologists' Use of Intensity-Modulated Radiation Therapy for Prostate Cancer" (Mitchell, JM, New England Journal of Medicine 369:17, October 24, 2013) and finds it to be methodologically flawed and factually inaccurate and, as such, does not contribute to the useful...

2013-10-21 12:27:52

RapidPlan is the first treatment planning tool that uses an evolving knowledge base to increase plan quality while streamlining the treatment planning process PALO ALTO, Calif., Oct. 21, 2013 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a radiotherapy treatment planning tool designed to enhance quality, consistency, and efficiency in radiotherapy treatment planning....

2013-10-08 08:29:03

SAVI is the first commercially available intracavitary APBI catheter in Japan ALISO VIEJO, Calif., Oct. 8, 2013 /PRNewswire/ -- Cianna Medical, Inc., a women?'s health company, today announced approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its SAVI(®) applicator in Japan. SAVI delivers accelerated partial breast irradiation (APBI), a 5-day course of targeted radiation for early-stage breast cancer patients. The Company has partnered with MC...

2013-10-02 08:30:21

ATLANTA, Oct. 2, 2013 /PRNewswire/ -- Esteya®, an electronic brachytherapy system, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), enabling medical centers in the United States to offer their patients with skin cancer a new treatment option. Esteya is a new approach for high precision skin cancer treatment. The system relies on a small, high dose rate (HDR) to apply radiation directly to the cancerous site. This direct delivery enables Esteya to focus...

2013-09-26 16:26:44

IMRIS and Varian developing cancer treatment system with potential to improve accuracy and effectiveness ATLANTA, Sept. 26, 2013 /PRNewswire/ -- IMRIS Inc. (NASDAQ: IMRS; TSX: IM) and Varian Medical Systems (NYSE: VAR) today announced that data presented here earlier this week at the American Society for Radiation Oncology (ASTRO) Annual Meeting demonstrates the potential to direct state-of-the-art radiation treatments using diagnostic-quality MR images at each treatment session....

2013-09-23 16:24:08

ATLANTA, Sept. 23, 2013 /PRNewswire/ -- ASTRO Booth #1115 -- The American Board of Radiology Foundation (ABRF) and Varian Medical Systems (NYSE: VAR) today announce that Varian is awarding a $100,000 second year renewal grant to the ABRF, to continue its work establishing a national brachytherapy registry. The registry, which is the first such nationwide modality-based project in radiation oncology, is linked to the American Board of Radiology's (ABR's) Innovation Pathway in...